Derrick Rossi Innovation Award Recipients

The University of Toronto Derrick Rossi Innovation Awards support the translation of groundbreaking research into real-world applications with significant socio-economic impact.

I am absolutely thrilled to see these innovative and potentially transformative proposals receive funding. This is a big win for science, discovery, and biomedical innovation! Kudos to the visionaries and their teams for driving these projects forward.

Dr. Derrick Rossi

2026 Recipients

Opher Baron

Joseph L. Rotman School of Management

Headshot of Professor Opher Baron

SiMLQ: Automated prescriptive digital twins for healthcare systems

Professor Opher Baron’s research focuses on queueing systems, service operations, analytics, and decision support in complex environments, especially healthcare. He develops methods to better understand congestion, resource allocation, and system performance, translating rigorous models into practical tools for real-world, time-sensitive challenges. Professor Baron aims to help healthcare systems improve patient flow, access, and efficiency by using existing resources more effectively.

Hospitals face rising congestion, long wait times, and increasing pressure on staff, yet most existing tools only describe past performance rather than help leaders test improvements. SiMLQ closes this gap by converting routine operational data into queueing-based digital twins that enable hospitals to evaluate staffing, routing, and workflow changes in advance, supporting better decisions and more efficient use of existing resources.


Ronald Kluger

Department of Chemistry

Headshot of Professor Ronald Kluger

Production and application of improved oxygen carriers for enhanced ex vivo organ preservation

Professor Ronald Kluger’s research looks at the chemistry of biomolecules, focusing on explaining how proteins and enzymes make life’s processes work. By designing specialized molecules that can attach to specific parts of proteins, his work helps scientists better understand how biological systems function and contributes to advances in medicine, biotechnology, and materials science.

Organ transplantation is limited by organ damage caused by ischemia—when oxygen is lost and then suddenly restored—leading to inflammation and tissue injury. Professor Kluger’s research focuses on developing improved strategies for supporting oxygen delivery during organ preservation to help reduce tissue damage associated with transplantation. These efforts are intended to improve organ viability and extend preservation times while facilitating the transport of donor organs.


Cindi Morshead

Department of Surgery

Headshot of Professor Cindi Morshead

Transforming stroke recovery: Reprogramming gene therapies for neural repair

Professor Cindi Morshead’s research focuses on neural stem cells and how they can be used to repair the brain and spinal cord after injury or disease. Her work has helped uncover how adult stem cells function, how they can be activated, and how they might be guided to repair or replace damaged cells in conditions such as stroke, spinal cord injury, and neurodegenerative disorders. By combining stem cell biology with approaches like tissue engineering and targeted drug delivery, her research aims to develop effective strategies for regenerating the central nervous system.

Brain disorders such as stroke and neurodegenerative disease cause irreversible loss of neurons, leaving millions with permanent impairments, yet no therapies exist to replace these cells despite their growing global impact. Professor Morshead developed a gene therapy platform that converts abundant astrocyte brain cells into functional neurons, replacing those lost to injury or disease and improving recovery in preclinical models, offering a promising new strategy for brain repair in stroke and neurodegenerative conditions.


David Sinton

Department of Mechanical and Industrial Engineering

Headshot of Professor David Sinton

Electrified recovery of critical minerals from sulphide tailings and ores

Professor David Sinton’s research focuses on fluid systems for energy applications, with an emphasis on carbon capture and conversion, industrial fluids, and clean energy technologies. His group develops practical solutions that improve energy efficiency and help transform carbon dioxide into valuable products.

Critical minerals needed for the low-carbon economy are often extracted using processes that consume large amounts of chemicals and generate environmentally harmful waste. This project, led by Professors David Sinton, Frank Gu, Vladimiros Papangelakis, and Jay Werber, is developing an electrochemical process that recycles key processing reagents, reducing waste and costs while enabling more sustainable recovery of valuable minerals—including from historic mine tailings—helping strengthen Canada's domestic critical mineral supply chain.


Xiao Yu (Shirley) Wu

Leslie Dan Faculty of Pharmacy

Headshot of Professor Shirley Wu

Translating a glucose-responsive microneedle patch technology for clinical feasibility and commercialization

Professor Shirley Wu’s research focuses on developing innovative drug delivery technologies that improve how medicines are delivered and targeted in the body. Her work includes smart microneedle patches for insulin and glucagon delivery, nanoparticle therapies for brain and central nervous system diseases, and nanomedicines for cancer treatment.

More than 537 million people worldwide live with diabetes—a number projected to reach 783 million by 2045—and many insulin-dependent patients are at risk of severe hypoglycemia, a potentially life-threatening drop in blood sugar. Professor Wu is developing a first-of-its-kind smart glucagon microneedle patch that automatically detects low blood sugar and delivers treatment, helping prevent dangerous hypoglycemic events before they become emergencies.


Ning Yan

Department of Chemical Engineering and Applied Chemistry

Headshot of Professor Ning Yan

Green lignin-based flame-retardant for composites

Professor Ning Yan’s research focuses on sustainable biopolymers and functional materials, developing bio-based alternatives to traditional chemicals for industrial applications. Her work, including pioneering lignin-based flame retardants, bridges fundamental science and real-world use across sectors such as forest products, chemicals, and automotive manufacturing. Through extensive publications, patents, and industry collaborations, she has helped advance practical, scalable solutions for more sustainable materials.

Advanced composites for applications like electric vehicle battery enclosures need flame retardants that are both high-performing and environmentally sustainable, but current options rely on harmful chemicals or add weight and reduce performance. Prof. Yan has developed lignin-based flame retardants from renewable sources that provide strong fire protection at low amounts while maintaining performance, supporting safer and more sustainable materials.


Ding Yuan

The Edward S. Rogers Sr. Department of Electrical and Computer Engineering

Headshot of Professor Ding Yuan

AI-native Platform for Automated Failure Diagnosis and Resolution

Professor Ding Yuan’s research focuses on systems software, with an emphasis on improving the reliability of large-scale computing systems. His work has been widely adopted in industry—powering applications from major tech companies to millions of connected electric vehicles—and contributes to key open-source platforms like Linux and Hadoop.

Software systems power critical services but suffer from inevitable failures, with diagnosis still largely manual—leading to high costs, downtime, and risk that are expected to grow with AI-driven development. Professor Yuan developed an AI-powered platform that automates real-time failure diagnosis and resolution using agents that analyze system data, correlate signals, and reason at scale. By transforming failure management into an automated, scalable process, it aims to reduce downtime, lower costs, and improve reliability in complex software systems.

2025 Recipients

In the award’s inaugural year, five outstanding projects were selected from a highly competitive pool of applications, and a total of $987,000 in funding has been awarded. These projects exemplify the spirit of innovation and collaboration that defines the University of Toronto (U of T) research community.

The Derrick Rossi Innovation Awards empower U of T researchers to turn bold ideas into real-world impact. We are proud to celebrate this year’s recipients and the remarkable potential of their work.

Professor Leah Cowen, Vice-President, Research and Innovation, and Strategic Initiatives


Chung-Wai Chow

Temerty Faculty of Medicine & Dalla Lana School of Public Health

Headshot of Professor Chow

Machine Learning Based System for Interpretation of Respiratory Oscillometry

Professor Chung-Wai Chow’s work is dedicated to improving equity and accessibility to pulmonary function testing for lung health. Despite advances in treatments, chronic lung diseases such as asthma and Chronic Obstructive Pulmonary Disease (COPD) remain the third-leading cause of death worldwide. This is due to the lack of patient access to PFTs, or Pulminary Function Tests that measure lung function. Oscillometry is an emerging PFT that has the advantage of portability, making it easily deployable in primary care or occupational health clinics settings. However, only a handful of specialists are trained to interpret oscillometry results.

Addressing this gap, Professor Chow’s research team has developed machine learning technology that interprets oscillometry results for clinicians. Developed using data from over 30,000 oscillometry tests, this tool can recognize abnormal findings, classifying them into lung function pattern categories characteristic to common lung diseases.


Molly Shoichet

Faculty of Applied Science and Engineering & Institute of Biomedical Engineering

Headshot of Professor Shoichet

Chase Biotherapeutics: Breaking barriers towards clinical translation for stroke recovery

University Professor Molly Shoichet’s research focuses on innovative drug and cell delivery strategies to overcome central nervous system-related pathologies in addition to 3D cell culture models for drug discovery in cancer. Her focus on strokes is due to their devastating effect on individuals and their families with few effective treatment options. More than 85% of stroke patients have no recovery options other than lengthy rehabilitation with limited results.

Revolutionizing treatment for stroke patients, the Shoichet lab invented a surgical treatment strategy for individuals requiring interventions beyond rehabilitation. Developed in collaboration with Professor Cindi Morshead’s lab, this treatment improves patient outcomes by using a regenerative approach to strengthen plasticity in brain models of stroke injury.


Peter Roy

Temerty Faculty of Medicine

Headshot of Professor Roy

Developing Novel Pro-Insecticides to Kill Mosquito Vectors of Disease

Mosquito-borne diseases are a major global health concern, affecting over 300 million people and causing one million deaths annually. These diseases, including malaria, dengue fever and West Nile virus, have been expanding geographically over the past decade due to climate change. Traditionally, small-molecule insecticides have been crucial in controlling mosquito populations and limiting disease transmission. However, mosquitoes have developed resistance to these chemicals through increased activity of cytochrome P450 enzymes, which help them break down and eliminate insecticides.

Addressing this problem of insecticide-resistance, Professor Roy’s lab has developed a novel cell-based screening technology called PEXIL that reveals compounds that can be transformed into lethal metabolites by the mosquito's P450 enzymes. In this way, the mosquito’s mechanism of insecticide resistance is turned against them.


Emma Master

Faculty of Applied Science & Engineering

Headshot of Professor Master

Upcycling underused and renewable plant biomass to biochemicals through integrated biotechnologies

Mounting environmental and political pressures are increasing societal interest in domestic manufacturing using renewable, sustainably sourced, and regionally available biomass feedstocks including underused residues from agriculture, agri-food and forest product sectors. In Canada alone, forest and agricultural sectors generate nearly 100 million tonnes of biomass residues. Today, such residues are left unused or underused as energy, resulting in a missed revenue opportunity and the release of greenhouse gases (GHGs). Transforming biomass residues to valuable biochemicals would open new economic opportunities for the forest, agricultural and chemical sectors, while reducing GHG emissions.

Addressing this opportunity, Professor Master’s lab created a technology that converts biomass residues from the forestry and biofuel sectors into biochemicals that have a growing market demand. An innovative enzymatic process converts hemicelluloses into glucaric acid, xylose and hydrogen peroxide, sought-after substances to produce chelators (binders that remove toxic metals from the body), cleansers, biopolymer precursors and food products.


Keith Pardee

Leslie Dan Faculty of Pharmacy

Headshot of Professor Pardee

Distributed Biomanufacturing for Improved Access to RNA Therapeutics

Despite major advances in RNA therapeutics and vaccines, high costs and centralized production mean these innovations remain inaccessible to many, especially in remote Canadian regions and low- and middle-income countries. Distributed, small-batch RNA biomanufacturing offers a promising and scalable solution, enabling localized production to support rare disease treatments, personalized medicine and global vaccine equity.

In collaboration with Professors Bowen Li, Leslie Dan Faculty of Pharmacy and Lindomar Pena, of the Oswaldo Cruz Foundation in Rio de Janeiro, Pardee and his team have developed an automated platform for small-batch RNA biomanufacturing, enabling local production of vaccines and other medicines, supporting treatments for rare diseases. This proof-of-concept device will be further engineered for automated synthesis and purification of an RNA SARS-CoV-2 vaccine for distribution.

VPRI Role

  • Administers the Derrick Rossi Innovation Awards in support of the U of T research community.

VPRI Contact

Staff